World Heart Day: Cinfa drives progress in cardiovascular research and development
 

(Middle East) - On the occasion of World Heart Day, Cinfa Group has highlighted the importance of maintaining a healthy lifestyle to reduce the rise of non-communicable diseases. The company is committed to and works tirelessly to offer solutions for cardiovascular diseases (CVD), one of its main therapeutic areas.

Cardiovascular disease is the leading cause of death worldwide. Conditions affecting the heart or blood vessels, such as heart attack, stroke, and heart failure, cause more than 1.4 million deaths annually in the Middle East and North Africa.

Dr. Alicia López de Ocáriz, Corporate Medical Director at Cinfa Group said: “Our challenge is to continue offering patients medicines that help in the treatment and prevention of cardiovascular diseases. That is why we continue to develop medicines in this area”.

She also has highlighted that “everything we do for these patients to improve their cardiac function will enhance their quality of life and reduce the number of hospitalizations”.

Cinfa offers a wide range of products that address several diseases such as hypercholesterolemia, hypertension, and heart failure, as well as its contribution in the prevention of cardiovascular diseases.

Taking advantage of World Heart Day, Cinfa aims to raise awareness about the prevention of cardiovascular diseases, as 80% of these conditions are preventable. Additionally, the company will contribute its expertise and join forces in the fight against these diseases by participating in the 35th Annual Congress of the Saudi Heart Association (SHA2024), taking place from October 10th to 12th.

PRINT THIS ARTICLE